"HEMATO ONCÓLOGOS, Instituto de Oncología, es una Institución prestadora de Servicios de Salud especializados en Hematología y Oncología con más de 20 años de experiencia, cuya filosofía es ofrecer atención integral a los pacientes, bajo la premisa de que es posible vivir con bienestar personal, familiar, laboral durante y después del cáncer. También se realizan pruebas COVID. Teléfono: 5184303"

During the past decade, Hemato Oncologos S.A. ( Site 1065) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hemato Oncologos S.A. ( Site 1065)" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hemato Oncologos S.A. ( Site 1065)" are "Prostatic Neoplasms" (2 trials), "Basal Cell Carcinoma" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hemato Oncologos S.A. ( Site 1065)" in a lesser frequency.

Most popular intervention types in "Hemato Oncologos S.A. ( Site 1065)" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials), "Avelumab" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hemato Oncologos S.A. ( Site 1065)" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hemato Oncologos S.A. ( Site 1065)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hemato Oncologos S.A. ( Site 1065), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hemato Oncologos S.A. ( Site 1065), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".